Last reviewed · How we verify
Healthy donor-derived FMT capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Healthy donor-derived FMT capsule (Healthy donor-derived FMT capsule) — Shanghai Zhongshan Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Healthy donor-derived FMT capsule TARGET | Healthy donor-derived FMT capsule | Shanghai Zhongshan Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Healthy donor-derived FMT capsule CI watch — RSS
- Healthy donor-derived FMT capsule CI watch — Atom
- Healthy donor-derived FMT capsule CI watch — JSON
- Healthy donor-derived FMT capsule alone — RSS
Cite this brief
Drug Landscape (2026). Healthy donor-derived FMT capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/healthy-donor-derived-fmt-capsule. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab